Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

UBS Downgrades Cano Health to Sell, Lowers Price Target to $3.75

Author: Benzinga Newsdesk | November 17, 2023 11:48am

UBS analyst Andrew Mok downgrades Cano Health (NYSE:CANO) from Neutral to Sell and lowers the price target from $12 to $3.75.

Posted In: CANO